TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16611567

Group type: EXPERIMENTAL
Intervention: Household ceramic water filters
Number of subjects: 60
Study: 12558230

Group type: EXPERIMENTAL
Intervention: Reminder group (audible and visual reminder at 225 minutes after preoperative antibiotics)
Number of subjects: 273

Group type: COMPARATOR
Intervention: Control group (no reminder)
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Reminder group
Number of subjects: 273

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 273

Group type: COMPARATOR
Intervention: Pre-study period
Number of subjects: 273
Study: 10824207

Group type: EXPERIMENTAL
Intervention: Routine chest radiography suggesting tuberculosis
Number of subjects: 273

Group type: COMPARATOR
Intervention: No chest radiography
Number of subjects: 273
Study: 8651143

Group type: EXPERIMENTAL
Intervention: Outpatient treatment for cocaine abuse
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Less educated patients who smoked or injected cocaine
Number of subjects: 0
Study: 1514915

Group type: EXPERIMENTAL
Intervention: Phenprocoumon (n = 66)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (n = 64)
Number of subjects: 130
Study: 6403933

Group type: EXPERIMENTAL
Intervention: Meptazinol (100 mg)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Morphine (15 mg)
Number of subjects: 63
Study: 31402571

Group type: COMPARATOR
Intervention: Thin liquid (control)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Xanthan gum-based thickener at 150 mPa s
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Xanthan gum-based thickener at 1400 mPa s
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Xanthan gum-based thickener (various viscosities)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Xanthan gum-based thickener at ≥450 mPa s
Number of subjects: 120
Study: 29489011

Group type: EXPERIMENTAL
Intervention: Computer‐based instruction (CBI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Behavioral Skills Training (BST)
Number of subjects: 0
Study: 26945767

Group type: EXPERIMENTAL
Intervention: Conventional perioperative antibiotics plus vancomycin and gentamicin injection (once)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Conventional perioperative antibiotics plus vancomycin and gentamicin injection (twice)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional perioperative antibiotics only (Control group)
Number of subjects: 60
Study: 24282083

Group type: EXPERIMENTAL
Intervention: Early invasive strategy (EIS)
Number of subjects: 9400

Group type: COMPARATOR
Intervention: Selectively invasive strategy (SIS)
Number of subjects: 9400
Study: 22863467

Group type: EXPERIMENTAL
Intervention: Dual-syringe power injector
Number of subjects: 275

Group type: COMPARATOR
Intervention: Syringeless power injector
Number of subjects: 275
Study: 20224282

Group type: EXPERIMENTAL
Intervention: Statin users
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-LLA users
Number of subjects: 0
Study: 18067630

Group type: EXPERIMENTAL
Intervention: Cryosurgery
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil (5-FU)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Topical Imiquimod (IMIQ)
Number of subjects: 75
Study: 16385220

Group type: EXPERIMENTAL
Intervention: Choice of 4 different types of condoms
Number of subjects: 414

Group type: COMPARATOR
Intervention: Standard clinic condom
Number of subjects: 414
Study: 12785625

Group type: EXPERIMENTAL
Intervention: phone-message prompt
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: phone-voice prompt
Number of subjects: 60

Group type: COMPARATOR
Intervention: no prompt
Number of subjects: 60
Study: 10491528

Group type: EXPERIMENTAL
Intervention: Continuous oral conjugated equine estrogen (ERT)
Number of subjects: 130

Group type: COMPARATOR
Intervention: No supplementation (non-ERT)
Number of subjects: 130
Study: 8686714

Group type: EXPERIMENTAL
Intervention: Low-dose dopamine (< 3 micrograms/kg/min)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 256
Study: 1897377

Group type: EXPERIMENTAL
Intervention: Physostigmine (acute, intravenous administration)
Number of subjects: 14
Study: 6344699

Group type: EXPERIMENTAL
Intervention: Epidural morphine (5 mg preservative-free morphine sulfate in 10 ml saline)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Epidural morphine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intravenous morphine
Number of subjects: 40
Study: 31367877

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT) via gastroscopy
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT) via colonoscopy
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT)
Number of subjects: 27
Study: 29503060

Group type: EXPERIMENTAL
Intervention: Citrulline (CIT) supplementation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Non-essential amino acids (NEAA)
Number of subjects: 24
Study: 28383434

Group type: EXPERIMENTAL
Intervention: High-pressure group (12 mm Hg, HP group, n=26)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Low-pressure group (8 mm Hg, LP group, n=20)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Open operation group (OP group, n=22)
Number of subjects: 68
Study: 25416927

Group type: EXPERIMENTAL
Intervention: Probiotic Lactobacillus casei Shirota (LcS)
Number of subjects: 0
Study: 24298897

Group type: EXPERIMENTAL
Intervention: Docetaxel-prednisone plus AT-101
Number of subjects: 1094

Group type: EXPERIMENTAL
Intervention: Prednisone plus sunitinib
Number of subjects: 1094

Group type: EXPERIMENTAL
Intervention: Radiographic progression
Number of subjects: 1094
Study: 22862854

Group type: EXPERIMENTAL
Intervention: Zirconia abutment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Titanium abutment
Number of subjects: 20
Study: 19054831

Group type: EXPERIMENTAL
Intervention: Sub-threshold micropulse diode laser photocoagulation (MPDL)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Conventional green laser photocoagulation (CGL)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Both MPDL and CGL
Number of subjects: 53
Study: 17894033

Group type: EXPERIMENTAL
Intervention: Clearfil Protect Bond (CPB)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Xeno III
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: GC Unifil Bond (GC)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Prime & Bond XP (P & B)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Adper Prompt L‐Pop (APL)
Number of subjects: 15
Study: 15646240

Group type: EXPERIMENTAL
Intervention: Simulated night shift (meals at 01:00/07:00 h and snack at 04:00 h)
Number of subjects: 8
Study: 11740389

Group type: EXPERIMENTAL
Intervention: Nifedipine 30 mg once daily
Number of subjects: 154

Group type: COMPARATOR
Intervention: Lisinopril 10 mg once daily
Number of subjects: 154
Study: 9212759

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 21
Study: 7959378

Group type: EXPERIMENTAL
Intervention: Invasive hemodynamic monitoring and treatment before operation (group A)
Number of subjects: 78

Group type: COMPARATOR
Intervention: No invasive hemodynamic monitoring before operation (group B)
Number of subjects: 78
Study: 3082645

Group type: EXPERIMENTAL
Intervention: h-GRF-44 2.5 micrograms
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: h-GRF-44 5 micrograms
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: h-GRF-44 10 micrograms
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: h-GRF-44 20 micrograms
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: h-GRF-44 40 micrograms
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: h-GRF-44 80 micrograms
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 31132547

Group type: EXPERIMENTAL
Intervention: Group occupational therapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Individual occupational therapy
Number of subjects: 70
Study: 29282199

Group type: EXPERIMENTAL
Intervention: Home-blotter A1C measurement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lab-blotter A1C measurement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Home-blotter and Lab-blotter A1C measurements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Home sampling preference
Number of subjects: 0
Study: 27842539

Group type: EXPERIMENTAL
Intervention: Mobile application designed to improve self-management of T2DM
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study: 25391196

Group type: EXPERIMENTAL
Intervention: High kVp technique with multi-layer filter
Number of subjects: 132

Group type: COMPARATOR
Intervention: Traditional copper filter
Number of subjects: 132
Study: 23062020

Group type: EXPERIMENTAL
Intervention: Integrative Meditation and Ear Acupressure (IMEA)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 56
Study: 20673972

Group type: EXPERIMENTAL
Intervention: Educational video
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo video
Number of subjects: 59
Study: 18201352

Group type: EXPERIMENTAL
Intervention: Topical application of calcipotriol or maxacalcitol ointment before phototherapy
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Topical application of calcipotriol or maxacalcitol ointment after phototherapy
Number of subjects: 6

Group type: COMPARATOR
Intervention: Phototherapy with PUVA or NB-UVB
Number of subjects: 6
Study: 16533076

Group type: EXPERIMENTAL
Intervention: Text chat
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Telephone
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Higher executive ability in AS participants
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Lower executive ability in AS participants
Number of subjects: 22

Group type: COMPARATOR
Intervention: Typically developing comparison group
Number of subjects: 22
Study: 12830260

Group type: EXPERIMENTAL
Intervention: Prisoners in security cells
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Prisoners in security cells with previous contact with prison psychiatric service
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-secluded inmates
Number of subjects: 30
Study: 10926433

Group type: EXPERIMENTAL
Intervention: Compomer
Number of subjects: 45

Group type: COMPARATOR
Intervention: Resin adhesive
Number of subjects: 45
Study: 8761382

Group type: EXPERIMENTAL
Intervention: Surgery plus post-operative radiotherapy (SR)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Surgery alone (S)
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Surgery plus post-operative radiotherapy (SR) in N2 group
Number of subjects: 308

Group type: COMPARATOR
Intervention: Surgery alone (S) in N2 group
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Surgery plus post-operative radiotherapy (SR) in N1 group
Number of subjects: 308

Group type: COMPARATOR
Intervention: Surgery alone (S) in N1 group
Number of subjects: 308
Study: 1330083

Group type: EXPERIMENTAL
Intervention: Glucomannan plus rifaximin 400 mg bid for 7 days each month
Number of subjects: 217

Group type: COMPARATOR
Intervention: Glucomannan only
Number of subjects: 217
Study: 6788433

Group type: EXPERIMENTAL
Intervention: 7 units of factor VIII per kg
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: 14 units of factor VIII per kg
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: 28 units of factor VIII per kg
Number of subjects: 339

Group type: COMPARATOR
Intervention: Low doses of factor VIII (7 or 14 units per kg)
Number of subjects: 339
Study: 30808949

Group type: EXPERIMENTAL
Intervention: Extensively hydrolyzed casein formula containing the probiotic L.rhamnosus GG (EHCF + LGG)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Soy formula (SF)
Number of subjects: 20
Study: 28181192

Group type: EXPERIMENTAL
Intervention: Single-pill triple combination of perindopril 5 mg/indapamide 1.25 mg/amlodipine 5 mg (Per/Ind/Aml)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Dual-pill combination of perindopril 5 mg/indapamide 1.25 mg + amlodipine 5 mg (Per/Ind + Aml)
Number of subjects: 148
Study: 25554014

Group type: EXPERIMENTAL
Intervention: Collaborative care intervention
Number of subjects: 401

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 401
Study: 23190017

Group type: EXPERIMENTAL
Intervention: Fostamatinib (R788)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Fostamatinib suspension
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Fostamatinib tablet
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Fostamatinib with food
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Single ascending dose of R406
Number of subjects: 3
Study: 20526624

Group type: EXPERIMENTAL
Intervention: Video-Assisted Thyroidectomy (VAT)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Conventional Thyroidectomy (CT)
Number of subjects: 112
Study: 19713982

Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17278225

Group type: EXPERIMENTAL
Intervention: Rigid proctoscope
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Flexible endoscope
Number of subjects: 41
Study: 16527796

Group type: EXPERIMENTAL
Intervention: NTI under curve-tipped suction catheter (CTSC) guidance (G[+] group)
Number of subjects: 131

Group type: COMPARATOR
Intervention: NTI without CTSC guidance (G[‐] group)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: NTI under CTSC guidance (G[+] group)
Number of subjects: 131
Study: 12743003

Group type: EXPERIMENTAL
Intervention: Persistently elevated immunocomplex (IC)-bound and/or serum IgA antibodies to C pneumoniae
Number of subjects: 4081

Group type: EXPERIMENTAL
Intervention: Serum IgA antibodies to hHsp60
Number of subjects: 4081

Group type: EXPERIMENTAL
Intervention: Persistently elevated CRP and C pneumoniae IC/IgA antibodies together
Number of subjects: 4081

Group type: EXPERIMENTAL
Intervention: CRP and hHsp60 IgA antibodies together
Number of subjects: 4081
Study: 10484540

Group type: EXPERIMENTAL
Intervention: Aerobic exercise for 12 weeks
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 17
Study: 8940863

Group type: EXPERIMENTAL
Intervention: Percutaneous endoscopic gastrostomy (PEG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Home care after PEG
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hospital care after PEG
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall survival rates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Care at home after PEG
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Complication development rate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quality of life improvement
Number of subjects: 0
Study: 1950351

Group type: EXPERIMENTAL
Intervention: Bed rest in hospital from 24 weeks gestation until delivery
Number of subjects: 19

Group type: COMPARATOR
Intervention: Conventional outpatient management
Number of subjects: 19
Study: 7020093

Group type: EXPERIMENTAL
Intervention: Niclofolan 2 mg/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Niclofolan 3 mg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 31848678

Group type: EXPERIMENTAL
Intervention: Midline unshifted adipofascial turn‐over flap
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Midline shifted adipofascial turn‐over flap
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Karydakis flap
Number of subjects: 192
Study: 30135778

Group type: EXPERIMENTAL
Intervention: Expert evaluation
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: User evaluation
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Neutral text
Number of subjects: 439

Group type: COMPARATOR
Intervention: Control (no information)
Number of subjects: 439
Study: 28392237

Group type: EXPERIMENTAL
Intervention: Molecular point-of-care testing (POCT) for respiratory viruses
Number of subjects: 720

Group type: COMPARATOR
Intervention: Routine clinical care (Control)
Number of subjects: 720
Study: 26017321

Group type: EXPERIMENTAL
Intervention: Substituting whole grain brown rice for polished (refined) white rice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Polished (refined) white rice
Number of subjects: 0
Study: 23823347

Group type: EXPERIMENTAL
Intervention: Chemomechanical method (papain gel)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional methods using low speed drills
Number of subjects: 60
Study: 20506993

Group type: EXPERIMENTAL
Intervention: Wavefront-optimized LASIK (ALLEGRETTO)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Conventional LASIK (LADAR4000)
Number of subjects: 51
Study: 18067499

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (10 mg/kg ev bolus followed by 1 mg/kg/hour perfusion)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control (saline matching the protocol)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 95
Study: 15694946

Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg/day for 4 weeks)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control (no statin)
Number of subjects: 38
Study: 12609944

Group type: EXPERIMENTAL
Intervention: Telephone review
Number of subjects: 278

Group type: COMPARATOR
Intervention: Face to face consultation
Number of subjects: 278
Study: 10533554

Group type: EXPERIMENTAL
Intervention: Assertive Community Treatment (ACT)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Usual services
Number of subjects: 152
Study: 8708970

Group type: EXPERIMENTAL
Intervention: Systemic beta-blockers
Number of subjects: 29

Group type: COMPARATOR
Intervention: Non-medicated group
Number of subjects: 29
Study: 1750779

Group type: EXPERIMENTAL
Intervention: Reminiscence group
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 54
Study: 7062419

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide, methotrexate and 5-fluorouracil combination chemotherapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Chloroethyl-cyclohexy-nitrosourea
Number of subjects: 40
Study: 31259673

Group type: COMPARATOR
Intervention: Albuterol (90 μg)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Albuterol (180 μg)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: FPS (100/50 μg)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: FPS (200/100 μg)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 28627929

Group type: EXPERIMENTAL
Intervention: Enhanced test, link-to-care, plus treat approach (TLC-Plus)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Financial incentives to increase linkage to care
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Financial incentives to increase viral suppression
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Computer-delivered intervention to decrease risk behavior
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Provider and patient surveys
Number of subjects: 76
Study: 26535951

Group type: EXPERIMENTAL
Intervention: Child-Parent Psychotherapy (CPP)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Psychoeducational Parenting Intervention (PPI)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standard Community Services (Control)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Nonmaltreating Mothers (Comparison Group)
Number of subjects: 44
Study: 23551511

Group type: EXPERIMENTAL
Intervention: 1.3% sodium hypochlorite (NaOCl)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine (CHX)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Tetraclean
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: MTAD
Number of subjects: 90

Group type: COMPARATOR
Intervention: Positive control
Number of subjects: 90

Group type: COMPARATOR
Intervention: Negative control
Number of subjects: 90
Study: 21915441

Group type: EXPERIMENTAL
Intervention: Partial coherence interferometry (PCI)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Ultrasound (US)
Number of subjects: 120
Study: 19794082

Group type: EXPERIMENTAL
Intervention: Vorinostat (400 mg daily for 21 days) in arm A
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Vorinostat (200 mg three times daily for 14 days followed by 1 week rest) in arm B
Number of subjects: 37
Study: 17535940

Group type: EXPERIMENTAL
Intervention: Consumer-assisted case management
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Non-consumer-assisted case management
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Standard clinic-based care
Number of subjects: 203
Study: 15547458

Group type: EXPERIMENTAL
Intervention: naltrexone 50 mg daily plus usual program treatment
Number of subjects: 145

Group type: COMPARATOR
Intervention: placebo plus usual treatment
Number of subjects: 145

Group type: COMPARATOR
Intervention: usual treatment alone
Number of subjects: 145
Study: 11707839

Group type: EXPERIMENTAL
Intervention: Methotrexate-based chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Whole-brain radiation therapy (WBRT)
Number of subjects: 0
Study: 9000657

Group type: EXPERIMENTAL
Intervention: HAT 0.5 mg/kg/week (n=4)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: HAT 1 mg/kg/week (n=2)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: HAT 0.5 mg/kg every other week (n=3)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: HAT 1 mg/kg every other week (n=3)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Historical controls (n=17)
Number of subjects: 12
Study: 8272759

Group type: EXPERIMENTAL
Intervention: Lipid lowering programme
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Different inclusion criteria for treatment
Number of subjects: 37
Study: 3548336

Group type: EXPERIMENTAL
Intervention: Hypertonic trisodium citrate anticoagulation
Number of subjects: 45

Group type: COMPARATOR
Intervention: Low-dose controlled heparin anticoagulation
Number of subjects: 45
Study: 30541572

Group type: EXPERIMENTAL
Intervention: Proprietary spearmint extract (PSE) 900 mg daily for 90 days
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 142
Study: 27184721

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus bevacizumab (CT+bevacizumab)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Chemotherapy alone (CT)
Number of subjects: 298
Study: 24554040

Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 197

Group type: COMPARATOR
Intervention: Routine
Number of subjects: 197
Study: 22391670

Group type: EXPERIMENTAL
Intervention: Nerve stimulation (NS) alone in Group A
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ultrasound guidance combined with nerve stimulation in Group B
Number of subjects: 60